
World Congress of Endometriosis May 14 London, England
OBGYN.net Conference CoverageFrom Society of Laparoscopic SurgeonsNew York, December, 1999
Dr.     Larry Demco: "I'd     like to introduce Dr. Sutton who's from London, England. I'd like to ask him     about the upcoming World Congress of Endometriosis. Dr. Sutton, could you     please give us a little background about the World Congress of     Endometriosis?"
     
     Professor     Christopher Sutton: "My name is     Professor Chris Sutton. I'm the Professor of Gynecological Surgery at the     University of Surrey in England. I'm on the Organizing Committee of the     'World Congress of Endometriosis: Endometriosis 2000,' which is being held     in London on the 14th of May for three days, I believe. It's a gathering of     anyone throughout the world who has a particular interest or expertise in     endometriosis, and this includes not only surgeons and physicians but also a     lot of basic scientists. The emphasis this year is not so much on the     surgery as such, although we'll feature that. It's mainly on the molecular     background, new advances, and particularly on the various new therapies like     immune modulators and anti-angiogenesis drugs which I think is going to take     the treatment of endometriosis forward in the next millennium."
     
     Dr. Larry Demco: "Could     you give us a little bit about endometriosis itself and what advantages     there would be to have all of these world experts get together to share     their knowledge? What do you think the future for endometriosis will     be?"
     
     Professor     Christopher Sutton: "I think the main     problem with endometriosis is that up to now, we really have no idea why it     happens. Is it really getting more frequent? Are we seeing more of this deep     infiltrating, very painful type of disease? A lot of people think so, but     the real problem is that we still don't really know what causes it. I think     there are now starting to be major breakthroughs, especially in molecular     biology, and I think that's what's going to be interesting in this     conference. We're going to see a completely new way of thinking about     it."
     
     Dr. Larry Demco: "That     sounds refreshing. What do you see on the surgery side, in view of     endometriosis?"
     
     Professor     Christopher Sutton: "At the very     beginning of the meeting, we're having a workshop which is really going to     be a think tank on the surgical treatment. Basically, we're getting as many     of the top people as are coming to meet together at the Chelsea and     Westminister Hospital just before the opening ceremony on Sunday morning.     We're all going to put our heads together and try and work out which way     surgery, in particular, is going to go in the next few years."
     
     Dr. Larry Demco: "What's     your opinion about the medical role for endometriosis?"
     
     Professor     Christopher Sutton: "I think right     now it's been rather disappointing because although it does suppress the     disease, in the vast majority of cases it seems to come back again once the     medication has stopped. So I think the type of medicine or drug therapy you     have at the moment will probably fade in insignificance, compared with the     surgical approach. And then I think a whole new generation of drugs which     actually looks at it completely differently will come into being, probably     within the next fifteen years."
     
     Dr. Larry Demco: "I'd     like to thank you, Dr. Sutton, for getting these experts together to get     them to share their ideas through your work with organizing the World     Congress of Endometriosis. All of us, patients and physicians, would like to     thank you very much."
     
     Professor     Christopher Sutton: "Thank you."
     
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
















